PIVOT-10: A phase II study of bempegaldesleukin (NKTR-214) in combination with nivolumab (NIVO) in cisplatin (cis) ineligible patients with previously untreated locally advanced or metastatic urothelial cancer (mUC)

Bamias, Aristotelis

Huddart, Robert A.

Siefker-Radtke, Arlene O.

Balar, Arjun Vasant

Bilen, Mehmet Asim

Powles, Thomas

Castellano, Daniel

Khalil, Maged F.

Van der Heijden, Michiel Simon

Koshkin, Vadim S.

Pook, David William

Ozguroglu, Mustafa

Santiago, Linda

Saab, Rabih

Li, Pao-Chen

Tagliaferri, Margit Cecile

Lin, Wei

Tagliaferri, Mary Ann

Loriot, Yohann